Immunotherapy Weekly articles from September 2002

Immunotherapy Weekly archives from September 2002

Exposure to bacteria modulates immune response and decreases allergy in farm children.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Findings from a Research Letter in the August 10, 2002, issue of the Lancet provide support for the idea that children who grow up on farms have fewer allergies because they are exposed to more microbes...

Excessive use of 'reliever' inhalers linked to increased risk of death.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Excessive use of "reliever" inhalers for asthma is linked to a significantly increased risk of dying from the disease, finds research in Thorax. The researchers based their findings on over 96,000...

AAAAI urges coaches, parents, players to recognize signs of exercise-induced asthma.(American Academy of Allergy, Asthma and Immunology)(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- As practice for college football and other fall sports begins, the American Academy of Allergy, Asthma and Immunology (AAAAI) encourages all athletes, coaches, trainers and parents to recognize the...

MediGene receives patents treatment with oncolytic herpes simplex viruses.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- The German-American biopharmaceutical company MediGene AG (MDG) announced that the U.S. Patent and Trademark Office has issued two patents (6,340,673 and 6,379,674) that are exclusively licensed to...

Positive clinical results support potential of AMD-3100 as new agent for stem cell transplant.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., announced that new clinical results from a phase I study in 18 healthy volunteers support the use of AMD-3100 as a potential new agent in stem cell transplant. Stem cell transplant...

Claritin approved in Japan.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) announced that Schering-Plough K.K., the company's subsidiary in Japan, has received approval to market the nonsedating antihistamine Claritin (loratadine) 10 mg Tablets as a...

Stressgen names Dr. Margot Northey to board of directors.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Stressgen Biotechnologies Corp. (SSB) announced that Dr. Margot Northey has been appointed to the board of directors. Northey was a professor and the dean of Queen's School of Business, Queen's...

Conmed comments on recent study on arthroscopy for osteoarthritis.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Conmed Corporation (CNMD) commented on recent activity in its stock and responded to the recent (July 2002) publication of a study in the New England Journal of Medicine concerning arthroscopic...

Incidence may have leveled off in U.S. kids.(asthma)(Brief Article)(Statistical Data Included)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Asthma rates may have leveled off in U.S. children after increasing in the 1980s and early 1990s, government research shows. Earlier data suggested a similar trend among adults, but more evidence...

Millennium discontinues oral MLN977 program.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (MLNM) will discontinue the development of its oral MLN977 program for the treatment of chronic asthma. This decision was made based on the findings of a...

Positive preclinical data on JNK inhibitors released.(c-Jun N-terminal kinase)(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) scientists, in association with collaborators at the National Heart and Lung Institute of Imperial College of Medicine in London, presented preclinical data at the World...

Steris, U.S. Army, enter R&D collaboration.(research & development)(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Steris Corp. (STE) announced that its subsidiary, Strategic Technology Enterprises, Inc., and the United States Army Edgewood Chemical Biological Center (ECBC) have entered into an agreement to conduct...

Protalex raises $1.2 million in private placement.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Protalex, Inc., (PRTX) announced that a recent private placement of its common stock plus warrants for future purchase (units) brought in more than $1.2 million to support ongoing operations and the...

MedImmune receives complete response letter from FDA for FluMist.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its Biologics License Application (BLA) for FluMist (influenza...

Protein Design Labs begins phase I clinical trial of Nuvion in ulcerative colitis.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc., (PDLI) announced that it has initiated a phase I clinical trial to evaluate the safety and tolerability of its humanized antibody Nuvion (visilizumab) in patients with...

FDA grants fast track status for Pyridorin.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- BioStratum Incorporated, a worldwide leader in drug development based on basal lamina research, announced that the FDA has granted Fast Track status to its lead drug candidate for diabetic kidney...

Ninth U.S. patent received.(Coley Pharmaceutical Group)(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 6,406,705, providing composition claims for CpG immunostimulants in combination with adjuvants....

Study evaluates impact of treatment with Remicade plus methotrexate.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Patients in a clinical study with moderately to severely active rheumatoid arthritis (RA) who achieve a clinical response with Remicade (infliximab), in combination with methotrexate, experienced...

The Immune Response Corp. announces proposed private offering of common stock and warrants.(Brief Article)
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (MNR) announced it is seeking to raise, subject to market and other conditions, up to $8 million in gross proceeds ($10.4 million if the 30% overallotment option is exercised)...

Asthma over-reported in the very obese.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Despite a high rate of self-reported asthma and bronchodilator use, very obese patients are actually at a low risk of objective airflow obstruction,...

Powerful new genital herpes drug studied at MCG.(Medical College of Georgia studies resiquimod)(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- An experimental drug that may diminish genital herpes outbreaks by helping the immune system find and fight the evasive virus is under study at the Medical College of Georgia. The immune response...

Immunotherapy shots take the sting out of fire ant bites.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Kenn Mingus knew something was dreadfully wrong 10 minutes after fire ants bit him. "My lips became numb; I had labored breathing, felt dizzy, and then I passed out," Mingus said. "I was rushed to...

Long-term study supports safety of Protopic for adults and children.(with atopic dermatitis)(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Data presented at the Academy 2002 summer meeting of the American Academy of Dermatology in New York City further validated the safety of Protopic (tacrolimus ointment) for long-term intermittent...

Pulsing patient's cells with tumor antigen could be effective cancer vaccine.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a patient's own immune response cells and antigens from tumor cells could be the best way to treat some patients with primary liver cancer. Newer...

Schering-Plough to appeal district court ruling on Claritin patent.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) announced that it disagreed with and would appeal a decision by a U.S. District Court judge that found that certain claims of a patent protecting against generic versions of...

MedImmune announces three new executives.(Pamela J. Lupien, Edward T. Mathers, and Lota S. Zoth)(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced the appointment of Pamela J. Lupien as vice president, human resources, Edward T. Mathers as vice president, corporate development, and Lota S. Zoth as vice president...

Involuntary smoke exposure affects severity among children.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Children with high levels of tobacco smoke exposure are more likely to have moderate or severe asthma, says a study conducted by the U.S. Centers for Disease Control and Prevention (CDC). While it...

Oxagen announces target validation collaboration with Pfizer.(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Oxagen, Ltd., a biotechnology company specializing in genetics-based target identification and validation, announced a collaborative research agreement with Pfizer to investigate the association of...

Incara IND for Liver Cell Transplantation Allowed by FDA.(Incara Pharmaceuticals Corp.)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corporation (INCR) announced it has been notified by the U.S. Food and Drug Administration (FDA) of their allowance of Incara's investigational new drug application (IND) to...

CDP 571 didn't meet primary endpoints in study.(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) and Celltech Group plc (CLL) announced that two phase III studies of CDP 571 did not meet the primary endpoints for patients with moderate-to-severe Crohn disease. The...

Tacrolimus ointment may be appropriate for children under age 2.(atopic dermatitis treatment)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Data presented at the Academy 2002 Summer Meeting of the American Academy of Dermatology in New York City suggests that tacrolimus ointment may be an effective and safe alternative for children under...

Company cites continued progress in R&D activities.(AtheroGenics Inc.)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, reported financial results for the 3 and 6 months ended June 30, 2002, reflecting...

Schering-Plough reports sales, earnings for 2002 second quarter.(Brief Article)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) reported financial results for the second quarter of 2002: diluted earnings per share for the 2002 second quarter were 43 cents on net income of $633 million, which is flat...

Versicor and Biosearch Italia agree to merge.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Versicor, Inc., (VERS) and Biosearch Italia SpA (BIO) announced that they have signed a definitive agreement and plan of merger whereby Biosearch will merge with and into Versicor in a stock-for-stock...

New tick-spread disease spurs education campaign.(Bartonella henselae or cat scratch disease)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Peak tick season is here, and patients are going to doctors with symptoms of early and late Lyme disease. Now there is a new wrinkle with this often hard to diagnose disease: some patients may...

Positive Synvisc data published.(by Genzyme Biosurgery)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Genzyme Biosurgery (GZBX), a division of Genzyme Corp., announced that two papers examining the clinical benefits and cost-effectiveness of Synvisc (Hylan G-F 20) have been published in the journal...

FDA stops shipments from major tissue bank, citing germ risk.(CryoLife Inc.)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- A Georgia tissue bank whose products are linked to a death and numerous serious infections is appealing the government's order that it quit distributing cadaver tissue because it can't guarantee the...

Findings give hope for H. pylori vaccine.(Helicobacter pylori)
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- The bacterium that causes stomach inflammation (gastritis), peptic ulcers and gastric cancer thrives in the human stomach by triggering changes in stomach cells and using those changes to its own...

Early pet exposure may reduce sensitivity to common allergens.
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Exposure to two or more cats or dogs in the first year of life may lower the risk of having allergic sensitization (positive skin test reactions) to cats and dogs and to other common allergens like...

Drug-free organ transplants possible for some patients.
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Results of three studies presented at the International Congress of the Transplantation Society provide encouraging evidence that a patient's immune system can be fooled into accepting a transplanted...

Antiallergic mattress covers have no clinical benefit.(for asthma treatment)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- The use of antiallergic mattress covers shows no clinical improvement in patients with moderate to severe asthma, who already use regular treatment. However, they do reduce the exposition of house dust...

Researchers discover how virus tricks the immune system.(herpes virus development studied)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Herpes viruses enter the body and hide away in cells, often re-emerging later to cause illnesses such as shingles, genital herpes and cancer. How these viruses evade the immune system remains...

ProdiGene, NIH begin study on oral vaccine derived from transgenic corn.(treatment against Traveler's Diarrhea)(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- ProdiGene, Inc., announced that it will begin a phase I clinical trial in cooperation with the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID),...

Teamm Pharmaceuticals acquires Histex line of products from Andrx.(Andrx Laboratories Inc.)(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Teamm Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that it has acquired the Histex line of products from Andrx Laboratories, Inc., a wholly owned subsidiary of Andrx Corp....

Robert C. Moellering, Jr., named to Ricerca's scientific advisory board.(Ricerca Biosciences L.L.C.)(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Ricerca Biosciences, LLC, a premier drug development partner to biotechnology and pharmaceutical companies, announced the appointment of Robert C. Moellering, Jr., MD, to its scientific advisory board...

Short-term pain can mean long-term gain for patients.(exercise helps treat knee osteoarthritis symptoms)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Research has repeatedly shown that regular exercise can provide long-term pain relief for those who suffer from knee osteoarthritis. Unfortunately, getting these patients to start an exercise...

Pilot Therapeutics says Airozin reduces leukotriene levels in asthmatics.(Pilot Therapeutics Holdings Inc.)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Pilot Therapeutics Holdings, Inc., (PLTT), a specialty pharmaceutical company developing and commercializing a portfolio of pharmaceutical and clinically validated over-the-counter products, announced...

Zadaxin increases survival rate in NIH animal model.(breast cancer treatment)(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals (SCLN) announced the positive results of a breast cancer animal model study using monotherapy Zadaxin as an immune system enhancer. At the 21-week endpoint of the study,...

Protein Design Labs announces second quarter 2002 results.(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Protein Design Labs (PDL), Inc., (PDLI) reported a net loss of $0.6 million, or $0.01 per basic and diluted share, for the 3 months ended June 30, 2002, compared with net income of $3.1 million, or...

Quorex Pharmaceuticals closes $10.6 million extension to series B round.(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Quorex Pharmaceuticals, Inc., a biopharmaceutical company using its drug discovery technologies to develop new classes of anti-infectives, announced it raised an additional $10.6 million in an...

Substance P blocker can prevent viral replication.(of HIV and other viral infections)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel agent that shows promise as a treatment for HIV and other viral infections. "Substance P (SP), a...

Genital wart cream confirmed as safe, effective in women.(imiquimod cream)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Recent international studies have shown that a patient-applied, immunomodulatory cream (imiquimod cream, 5%) is safe and effective in treating women with the highly contagious sexually transmitted...

Serono and Genentech announce international marketing agreement for Raptiva.(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Serono, S.A., (SRA) and Genentech, Inc., (DNA) announced that the two companies have entered into an agreement under which Serono will receive an exclusive license to market the psoriasis treatment...

The American Stock Exchange approves plan submitted by Cel-Sci.(Brief Article)
September 18, 2002... 2002 SEP 18 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corp. (CVM), a developer of cancer immuno-therapy treatments, announced that the American Stock Exchange (AMEX) has accepted the company's plan to bring itself into compliance with the AMEX...

Researchers identify gene involved.(in the regulation of autoimmune disease)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Researchers have identified a gene that appears to be a critical factor in autoimmune disease, according to a study to be published in the journal Science. The research, performed by scientists at...

Immune system supressor drug found effective in treating precancerous blood disorder.(antithymocyte globulin treats myelodysplastic syndrome)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- A medicine typically used in organ transplant patients shows promise in treating older patients who have a precancerous blood disorder for which there is currently no effective treatment besides blood...

Murabatide safely improves immune response to infection.
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel agent can greatly enhance the immune response to HIV infection, researchers in France say. "The safe synthetic immunomodulator Murabutide (ISTAC...

Ragweed season in full swing.
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Across the United States, August 15 marked the beginning of ragweed season, according to the American Academy of Allergy, Asthma and Immunology (AAAAI). A stubborn, prolific plant, pollen released...

New drugs, novel use of therapies, enhance transplant success.(Brief Article)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- New side-effect sparing drugs and prophylactic uses of acute immunosuppressive therapies such as novel antimetabolites, monoclonal, and polyclonal antibodies are furthering the success of transplants...

Orathecin receives orphan-drug designation for treatment of pediatric AIDS.(SuperGen Inc.)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc., (SUPG) announced that its oral anticancer cancer compound Orathecin has received orphan-drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of pediatric...

Researchers hope to use cow clones as medicine factories.(Hematech L.L.C.)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Four cloned calves genetically engineered with human DNA and currently grazing in Iowa could hold the key to creating herds of identical cows that produce medicines in their milk and blood. "Cows...

Genomics technology company reports total revenues increased 11%.(Genencor International Inc.)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) reported that, for the quarter ended June 30, 2002, total revenues were $90.6 million, compared with $81.3 million for the second quarter of 2001. Product...

Nabi product sales growth drives positive cash flow.(Nabi Biopharmaceuticals )
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) reported net income of $0.8 million in the second quarter of 2002, or $0.02 per share, in line with external expectations. This earnings performance contributed to...

The Quigley Corp. second quarter revenue up 25%.(Brief Article)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- The Quigley Corp. (QGLY) announced revenue of $5.7 million for the second quarter ended June 30, 2002, a 25% increase over the $4.6 million in revenue reported for the second quarter of 2001. For...

Vertex reports second quarter and first half 2002 financial results.(Vertex Pharmaceuticals Inc.)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Vertex Pharmaceuticals, Inc., (VRTX) reported financial results today for the 3 and 6 months ended June 30, 2002. For the 3 months ending June 30, 2002, the company's net loss was $21.0 million,...

Sunesis receives NIH grant to develop new HIV therapies.(Sunesis Pharmaceuticals Inc.)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced that the company has been granted a $600,000, 2-year phase I Small Business Innovative Research grant from the National Institute of Allergy and Infectious...

Ribapharm files patent infringement lawsuit in Germany against Hoffmann-La Roche.(ribavirin patent lawsuit)(Brief Article)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Ribapharm, Inc., (RNA) announced that it has filed legal action against F. Hoffmann-La Roche in Germany to enforce its patents on the use of ribavirin. On August 6, the company announced that it...

Analex's Advanced Biosystems subsidiary awarded $3M biodefense contract.
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Analex Corporation (ANLX) announced that its Advanced Biosystems, Inc., subsidiary has been awarded a new $3 million contract by the Defense Advanced Research Projects Agency (DARPA). This 8-month...

Zadaxin produces sustained responses in hard-to-treat hepatitis B patients.(thymalfasin, thymosin alpha 1 from SciClone Pharmaceuticals Inc. )
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals, Inc., (SCLN) announced the results of a new study demonstrating that Zadaxin (thymalfasin, thymosin alpha 1) helps clear the hepatitis B virus in the most difficult to treat...

Company achieves research breakthrough using tethering technology.(Sunesis Pharmaceuticals Inc. discovers interleukin-2 inhibitor)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced the discovery of a potent, small molecule inhibitor of interleukin-2 (IL-2), providing the most advanced proof of principle to date of the company's "tethering"...

Study: Subcutaneous MabCampath/Campath effective.(alemtuzumab effective in treatment of fludarabine refractory B-cell chronic lymphocytic leukemia )(Brief Article)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Subcutaneous administration of the monoclonal antibody, MabCampath/Campath (alemtuzumab), approved for treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (B-CLL) patients (33%...

Smith & Nephew receives clearance for antibiotic-coated orthopedic device.(OrthoGuard AB brand antimicrobial sleeve)(Brief Article)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Smith & Nephew (SNN) announced that the United States Food and Drug Administration (FDA) 510k clearance of OrthoGuard AB brand antimicrobial sleeve, the orthopedic industry's first antibiotic-coated...

New analysis points to 2004 finish for phase III study of pemtumomab.(Antisoma PLC)
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Antisoma, plc, the U.K.-based biopharmaceutical company developing new drugs for cancer, announced the result of an independent statistical analysis refining the predicted completion time for its...

Operational changes announced.(Targeted Genetics Corp. )
September 25, 2002... 2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corp. (GEN) announced that it is restructuring its operations to reduce expenses and concentrate its resources on key product development programs and continuing business development...